Immune Checkpoint Inhibitors in the Treatment of Lymphomas
Programmed death receptors and ligands (PD-1 and PD-L1) are the best studied immune checkpoints (ICP) and are considered to be key factors of immune response control. The ability of tumor cells to affect the ICP receptors is one of the principal mechanisms of suppressing antitumor immunity. The deve...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Practical Medicine Publishing House
2018-10-01
|
| Series: | Kliničeskaâ onkogematologiâ |
| Subjects: | |
| Online Access: | http://bloodjournal.ru/wp-content/uploads/2018/09/4-1.pdf |